Editorial
World J Gastroenterol
31(10):101838.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101838
Abstract (319)
|
Core Tip (364)
|
Full Article (HTML) (1469)
|
Full Article (PDF)-378K (104)
|
Full Article with Cover (PDF)-633K (67)
|
Full Article (XML)-71K (60)
|
Audio-3309K (16)
|
Peer-Review Report-245K (48)
|
Answering Reviewers-157K (53)
|
Received: 09/28/2024
|
Revised: 01/23/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3038)
|
Similar Articles (143)
|
Timeline of Article Publication (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Review
Overcoming antibiotic-resistant Helicobacter pylori infection: Current challenges and emerging approaches

World J Gastroenterol
31(10):102289.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102289
Abstract (384)
|
Core Tip (354)
|
Full Article (HTML) (5460)
|
Figures (1-1) (308)
|
Tables (1-3) (312)
|
Full Article (PDF)-4025K (317)
|
Full Article with Cover (PDF)-4275K (108)
|
Full Article (XML)-507K (63)
|
Audio-1047K (27)
|
Peer-Review Report-271K (50)
|
Answering Reviewers-120K (66)
|
Received: 10/13/2024
|
Revised: 11/28/2024
|
Accepted: 01/17/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (8563)
|
Similar Articles (333)
|
Timeline of Article Publication (14)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
World J Gastroenterol
31(10):103454.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103454
Abstract (302)
|
Core Tip (342)
|
Full Article (HTML) (1657)
|
Figures (1-1) (273)
|
Full Article (PDF)-1122K (104)
|
Full Article with Cover (PDF)-1376K (92)
|
Full Article (XML)-113K (56)
|
Audio-412K (17)
|
Peer-Review Report-223K (56)
|
Answering Reviewers-109K (46)
|
Received: 11/20/2024
|
Revised: 12/31/2024
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4037)
|
Similar Articles (1771)
|
Timeline of Article Publication (10)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Control Study
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes

World J Gastroenterol
31(10):103716.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103716
Abstract (323)
|
Core Tip (365)
|
Full Article (HTML) (1460)
|
Figures (1-1) (268)
|
Tables (1-6) (258)
|
Full Article (PDF)-876K (81)
|
Full Article with Cover (PDF)-1130K (61)
|
Full Article (XML)-191K (54)
|
Audio-454K (25)
|
Peer-Review Report-229K (45)
|
Answering Reviewers-124K (36)
|
Supplementary Material-657K (49)
|
Received: 11/27/2024
|
Revised: 01/16/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (4187)
|
Similar Articles (37)
|
Timeline of Article Publication (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Endoscopic full-thickness resection: A definitive solution for local complete resection of small rectal neuroendocrine neoplasms

World J Gastroenterol
31(10):100444.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100444
Abstract (341)
|
Core Tip (356)
|
Full Article (HTML) (1335)
|
Figures (1-4) (264)
|
Tables (1-3) (278)
|
Full Article (PDF)-8140K (126)
|
Full Article with Cover (PDF)-8392K (86)
|
Full Article (XML)-121K (50)
|
Audio-885K (33)
|
Peer-Review Report-197K (57)
|
Answering Reviewers-155K (57)
|
Supplementary Material-123K (49)
|
Received: 08/16/2024
|
Revised: 12/11/2024
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4494)
|
Similar Articles (17)
|
Timeline of Article Publication (11)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
World J Gastroenterol
31(10):102393.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102393
Abstract (329)
|
Core Tip (362)
|
Full Article (HTML) (1273)
|
Figures (1-2) (300)
|
Tables (1-3) (280)
|
Full Article (PDF)-3168K (117)
|
Full Article with Cover (PDF)-3422K (86)
|
Full Article (XML)-97K (64)
|
Audio-586K (21)
|
Peer-Review Report-221K (65)
|
Answering Reviewers-311K (56)
|
Supplementary Material-128K (54)
|
Received: 10/16/2024
|
Revised: 01/04/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (4233)
|
Similar Articles (3)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Circular RNA contributes to gastric cancer by targeting Wnt family member 2B as a competing endogenous RNA

World J Gastroenterol
31(10):99583.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.99583
Abstract (299)
|
Core Tip (325)
|
Full Article (HTML) (1075)
|
Figures (1-6) (272)
|
Full Article (PDF)-10367K (106)
|
Full Article with Cover (PDF)-10622K (105)
|
Full Article (XML)-108K (54)
|
Audio-200K (12)
|
Peer-Review Report-203K (56)
|
Answering Reviewers-316K (88)
|
Received: 10/23/2024
|
Revised: 12/26/2024
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2875)
|
Similar Articles (1191)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Platelet activation relieves liver portal hypertension via the lymphatic system though the classical vascular endothelial growth factor receptor 3 signaling pathway

World J Gastroenterol
31(10):100194.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100194
Abstract (298)
|
Core Tip (307)
|
Full Article (HTML) (1370)
|
Figures (1-8) (299)
|
Full Article (PDF)-42475K (125)
|
Full Article with Cover (PDF)-42729K (80)
|
Full Article (XML)-113K (57)
|
Audio-352K (18)
|
Peer-Review Report-309K (47)
|
Answering Reviewers-116K (47)
|
Supplementary Material-190K (52)
|
Received: 08/09/2024
|
Revised: 12/16/2024
|
Accepted: 01/21/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (3336)
|
Similar Articles (142)
|
Timeline of Article Publication (11)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Lactococcus garvieae aggravates cholestatic liver disease by increasing intestinal permeability and enhancing bile acid reabsorption

World J Gastroenterol
31(10):101014.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101014
Abstract (288)
|
Core Tip (339)
|
Full Article (HTML) (1312)
|
Figures (1-6) (267)
|
Tables (1-1) (271)
|
Full Article (PDF)-10815K (120)
|
Full Article with Cover (PDF)-11065K (89)
|
Full Article (XML)-143K (60)
|
Audio-400K (16)
|
Peer-Review Report-253K (51)
|
Answering Reviewers-98K (51)
|
Supplementary Material-270K (59)
|
Received: 09/03/2024
|
Revised: 12/19/2024
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4408)
|
Similar Articles (18)
|
Timeline of Article Publication (5)
|
Authors Evaluation (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
SEL1L-mediated endoplasmic reticulum associated degradation inhibition suppresses proliferation and migration in Huh7 hepatocellular carcinoma cells

World J Gastroenterol
31(10):103133.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103133
Abstract (310)
|
Core Tip (337)
|
Full Article (HTML) (1273)
|
Figures (1-7) (292)
|
Full Article (PDF)-9623K (112)
|
Full Article with Cover (PDF)-9876K (71)
|
Full Article (XML)-121K (49)
|
Audio-824K (16)
|
Peer-Review Report-275K (43)
|
Answering Reviewers-363K (53)
|
Supplementary Material-48K (38)
|
Received: 11/10/2024
|
Revised: 01/04/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3324)
|
Similar Articles (1752)
|
Timeline of Article Publication (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers: Feasible or not feasible?

World J Gastroenterol
31(10):100771.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100771
Abstract (312)
|
Core Tip (354)
|
Full Article (HTML) (737)
|
Figures (1-1) (270)
|
Tables (1-2) (282)
|
Full Article (PDF)-471K (67)
|
Full Article with Cover (PDF)-728K (53)
|
Full Article (XML)-61K (55)
|
Audio-512K (21)
|
Peer-Review Report-257K (41)
|
Answering Reviewers-156K (49)
|
Received: 08/25/2024
|
Revised: 01/10/2025
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2641)
|
Similar Articles (24)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102580.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102580
Abstract (352)
|
Core Tip (378)
|
Full Article (HTML) (1140)
|
Tables (1-1) (326)
|
Full Article (PDF)-370K (85)
|
Full Article with Cover (PDF)-625K (62)
|
Full Article (XML)-56K (56)
|
Audio-2970K (15)
|
Peer-Review Report-217K (47)
|
Answering Reviewers-149K (48)
|
Received: 10/22/2024
|
Revised: 01/16/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (2939)
|
Similar Articles (165)
|
Timeline of Article Publication (3)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102725.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102725
Abstract (321)
|
Core Tip (345)
|
Full Article (HTML) (2855)
|
Figures (1-1) (281)
|
Full Article (PDF)-1500K (128)
|
Full Article with Cover (PDF)-1754K (84)
|
Full Article (XML)-97K (56)
|
Audio-476K (24)
|
Peer-Review Report-468K (48)
|
Answering Reviewers-1818K (64)
|
Received: 10/27/2024
|
Revised: 01/16/2025
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4717)
|
Similar Articles (249)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Treatment of intermediate-to-advanced unresectable hepatocellular carcinoma is shifting toward a multidisciplinary strategy that includes multiple modalities as needed

World J Gastroenterol
31(10):103420.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103420
Abstract (306)
|
Core Tip (331)
|
Full Article (HTML) (1132)
|
Figures (1-1) (253)
|
Tables (1-1) (275)
|
Full Article (PDF)-578K (77)
|
Full Article with Cover (PDF)-834K (104)
|
Full Article (XML)-91K (34)
|
Audio-833K (20)
|
Peer-Review Report-243K (34)
|
Answering Reviewers-100K (34)
|
Received: 11/18/2024
|
Revised: 01/31/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3048)
|
Similar Articles (1752)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):103973.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103973
Abstract (312)
|
Core Tip (357)
|
Full Article (HTML) (2668)
|
Full Article (PDF)-406K (179)
|
Full Article with Cover (PDF)-661K (121)
|
Full Article (XML)-95K (63)
|
Audio-989K (16)
|
Peer-Review Report-215K (42)
|
Answering Reviewers-118K (52)
|
Received: 12/05/2024
|
Revised: 01/24/2025
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4327)
|
Similar Articles (2)
|
Timeline of Article Publication (2)
|
Authors Evaluation (4)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy

World J Gastroenterol
31(10):104429.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.104429
Abstract (307)
|
Core Tip (296)
|
Full Article (HTML) (896)
|
Tables (1-1) (263)
|
Full Article (PDF)-366K (73)
|
Full Article with Cover (PDF)-621K (99)
|
Full Article (XML)-45K (55)
|
Audio-1658K (21)
|
Peer-Review Report-175K (37)
|
Answering Reviewers-38K (44)
|
Received: 12/19/2024
|
Revised: 01/13/2025
|
Accepted: 01/24/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2636)
|
Similar Articles (1803)
|
Timeline of Article Publication (3)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open